Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
This study will maximize identification of women with Lynch Syndrome using an enhanced
screening strategy to identify those at risk. These women will be referred to genetic
counselling for testing and those found to have Lynch Syndrome will be asked to invite first
degree relatives to participate and undergo genetic testing for Lynch Syndrome. Screening
guidelines and risk reducing surgery options for participants found to have Lynch Syndrome
will be reinforced by the study and adherence to these guidelines will be assessed annually
for ten years following Lynch Syndrome diagnosis to assess the impact and cost-effectiveness
of this enhanced screening approach.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society